News

Refine by category
Refine by year
- 2020
- 2019
- 2018
- Archive

Press Releases —

Concordia International Corp. Announces Name Change to ADVANZ PHARMA Corp.

29 Nov 2018

Concordia International Corp. ("Concordia" or "the Company") (TSX: CXR), today announced that shareholder
Learn more
Press Releases —

Third quarter 2018 results announced

14 Nov 2018

Third quarter net income of $1.8 billion, which includes a $1.9 billion gain on debt settlement as part o
Learn more
Press Releases —

Concordia International Corp. Announces Release Date for Third Quarter 2018 Results

31 Oct 2018

Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharm
Learn more
Press Releases —

Concordia International Corp. Adds European Pharmaceutical Industry Expert to its Board of Directors

29 Oct 2018

Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharm
Learn more
Press Releases —

Pharmaceutical industry expert added to board of directors

15 Oct 2018

International specialty pharmaceutical company focused on becoming a leader in European specialty, off-pa
Learn more
Press Releases —

Concordia International Corp. announces intention to rebrand as ADVANZ PHARMA following its successful recapitalization

09 Oct 2018

The Company intends to rebrand as ADVANZ PHARMA during the fourth quarter of 2018.
Learn more
Press Releases —

Special meeting of shareholders announced to approve name change

05 Oct 2018

The Name Change is subject to approval by Limited Voting Shareholders ("Shareholders") at the Meeting.
Learn more
Press Releases —

Further update provided on recently completed recapitalization transaction and the issue price of its private placement

12 Sep 2018

As described in the Company's management information circular dated May 15, 2018, and previous press rele
Learn more
Investors —

Update on the Recapitalization Transaction

13 Aug 2018

Update on the implementation of Concordia's recapitalization transaction.
Learn more
Investors —

Concordia International corp. announces second quarter 2018 results

08 Aug 2018

Update On Concordia's Recently Completed Recapitalization
Learn more
Investors —

Concordia International corp. announces release date for second quarter 2018 results

25 Jul 2018

Concordia International Corp. Announces Second Quarter 2018 Results
Learn more
Investors —

Concordia International corp. announces release date for second quarter 2018 results

25 Jul 2018

Update on Concordia's Recapitalization Transaction
Learn more
Investors —

Concordia International corp. announces NASDAQ delisting

19 Jul 2018

Concordia Completes Recapitalization Transaction
Learn more

News

Refine by category

Refine by year

Press Releases —

Concordia International Corp. Announces Name Change to ADVANZ PHARMA Corp.

Press Releases —

Third quarter 2018 results announced

Press Releases —

Concordia International Corp. Announces Release Date for Third Quarter 2018 Results

Press Releases —

Concordia International Corp. Adds European Pharmaceutical Industry Expert to its Board of Directors

Press Releases —

Pharmaceutical industry expert added to board of directors

Press Releases —

Concordia International Corp. announces intention to rebrand as ADVANZ PHARMA following its successful recapitalization

Press Releases —

Special meeting of shareholders announced to approve name change

Press Releases —

Further update provided on recently completed recapitalization transaction and the issue price of its private placement

Investors —

Update on the Recapitalization Transaction

Investors —

Concordia International corp. announces second quarter 2018 results

Investors —

Concordia International corp. announces release date for second quarter 2018 results

Investors —

Concordia International corp. announces release date for second quarter 2018 results

Investors —

Concordia International corp. announces NASDAQ delisting

Featured News

Get up-to-date news direct to your inbox.

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors

ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results